November 1, 2024

The Pathology of Stargardt Disease and Future Treatment Horizons

By Joseph C. Giacalone, MD, PhD, Brittni A. Scruggs, MD, PhD

October 25, 2024

Paul Hahn, MD, PhD, Discusses Physician Reimbursement at AAO

By Paul Hahn, MD, PhD

October 18, 2024

Transformative Strategies in Ocular Oncology Presented at AAO 2024

By Jim Gallagher, senior managing editor

October 1, 2024

Clinical Trial Download: The Potential of Optogenetic Therapy

By Yasha Modi, MD , Allen C. Ho, MD, Sulagna Bhattacharya, MBA

October 1, 2024

Participating in Clinical Trials as a Retina Specialist

By David A. Eichenbaum, MD

October 1, 2024

Anti-VEGF Therapy for Retinopathy of Prematurity

By Vernon S. Volante, BS, Lauren C. Kiryakoza, MD, Hong-Uyen Hua, MD

November 1, 2023

History, Symptoms, and Management of Coats Disease

By Jay K. Rathinavelu, BSE, Grant A. Justin, MD, Lejla Vajzovic, MD, FASRS

November 1, 2023

Clinical Pearls for Pediatric Retinal Detachment

By Seyyedehfatemeh Ghalibafan, MD, Louis Z. Cai, MD, Audina M. Berrocal, MD, et al.

November 1, 2023

Keeping Up With ICROP

By Brittni A. Scruggs, MD, PhD, Reeda Bou Said, MD

November 1, 2023

UPFRONT: New Treatments for Infant Retina Patients

By Peter K. Kaiser, MD

October 1, 2023

CODING Q&A: Billing Pediatric Retina Cases

By Matthew Baugh, MHA, COT, OCS, OCSR

October 1, 2022

SUBSPECIALTY NEWS: FDA approves Cimerli, GATHER2 GA trial meets primary endpoint, and more.

By Rochelle Nataloni, contributing writer

March 1, 2022

FUTURE FILE: Highlighting innovative early-stage and preclinical concepts in retina

By Jerry Helzner, contributing editor

March 1, 2022

SUBSPECIALTY NEWS: Results in suprachoroidal trial, RNA therapy for RP, Beovu in DME, and more.

By Rochelle Nataloni, contributing writer